Rapid Dose Therapeutics Corp. (RDTCF)
OTCMKTS
· Delayed Price · Currency is USD
0.1393
-0.0407 (-22.61%)
At close: Apr 8, 2025
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 501.69K CAD in the quarter ending November 30, 2024, with 114.57% growth. This brings the company's revenue in the last twelve months to 1.61M, up 53.98% year-over-year. In the fiscal year ending February 29, 2024, Rapid Dose Therapeutics had annual revenue of 1.02M with 42.06% growth.
Revenue (ttm)
1.61M CAD
Revenue Growth
+53.98%
P/S Ratio
13.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.76M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
Rapid Dose Therapeutics News
- 3 months ago - Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt - Newsfile Corp
- 2 years ago - Rapid Dose Announces Proposed Private Placement Financing - Business Wire
- 2 years ago - Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order - Business Wire
- 2 years ago - Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program in Partnership with Maryland Tech Council and Canada's Trade Commissioner Service - Business Wire
- 2 years ago - Rapid Dose Therapeutics Enters Supplier and Purchase Agreement with a Leading Gas and Convenience Store Retailer for Nutraceutical and Vitamin Products - Business Wire
- 2 years ago - Rapid Dose Therapeutics Confirms Delay in Filing Annual Financial Statements and Issuance of Failure-to-File Cease Trade Order - Business Wire
- 2 years ago - Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update - Business Wire
- 2 years ago - Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement - Business Wire